Search
for
Sort by
Research 211–240 of 655
- Male fertility and skin diseases
- Polymorphisms in androgen and estrogen receptor genes: effects on male aging
- The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Testosterone Treatment in Women – An Overview
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- The role of androgens in hormone replacement therapy
- The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
- Androgen Receptor Ligands: Agonists and Antagonists
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity
- Integrative insights into polycystic ovarian syndrome (PCOS): A comparative review of unani and modern medical perspective
- Phytochemicals as Modulators of Human Endocrine Function: Bridging Traditional Remedies and Hormonal Health
- Farmácia dos Clérigos - Porto e nos Serviços Farmacêuticos da University College Hospital - Londres, Reino Unido, ao abrigo do programa Erasmus+
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Understanding Polycystic Ovary Syndrome
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Androgen excess: a hallmark of polycystic ovary syndrome
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives